A9579 HCPCS Level II code: Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml

A9579 is the HCPCS code for “Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

A9579

Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml

Short description: Gad-base mr contrast nos,1ml

HCPCS · United States

Medicare details

The indicators CMS publishes with A9579 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Drugs
Type of service
Diagnostic radiology
BETOS category
Standard imaging - nuclear medicine
Added
Jan 1, 2008

Where A9579 sits

  1. 1A codesAmbulance, supplies and miscellaneous
  2. 2Active code A9579Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code A9579 mean?

A9579 is the HCPCS code for “Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover A9579?

CMS lists A9579’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.